Abstract
Exitron splicing (EIS) events in cancers can disrupt functional protein domains to cause cancer driver effects. EIS has been recognized as a new source of tumor neoantigens. Here, we describe an integrated protocol for EIS and EIS-derived neoantigen identification using RNA-seq data. The protocol constitutes a step-by-step guide from data collection to neoantigen prediction. For complete details on the use and execution of this protocol, please refer to Wang et al. (2021).
| Original language | English (US) |
|---|---|
| Article number | 100788 |
| Journal | STAR Protocols |
| Volume | 2 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 17 2021 |
Bibliographical note
Publisher Copyright:© 2021 The Author(s)
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bioinformatics
- Cancer
- Genetics
- Genomics
- Immunology
- RNAseq
Fingerprint
Dive into the research topics of 'Integrated protocol for exitron and exitron-derived neoantigen identification using human RNA-seq data with ScanExitron and ScanNeo'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS